²é¿´: 986  |  »Ø¸´: 4
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÑÌÔÆÌýÓê

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

½ð³æ

[ÇóÖú] Çó·­ÒëÒ»¶ÎÓ¢ÎÄÎÄÏ×(Óлú»¯Ñ§)

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s
disease (41¨C44). Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate
these receptors and probe their function (43, 44). Table 1 summarizes
the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.

» ²ÂÄãϲ»¶

ÄîÄî²»Íü£¬±ØÓлØÏì
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

ÑÌÔÆÌýÓê(½ð±Ò+10, ·­ÒëEPI+1): 1 2011-07-19 12:25:35
ÇëÄã°´ÕÕ°æ¹æÈ·¶¨½ð±ÒÊýÁ¿£¬Ì«ÉÙÁËÒ»°ã²»Ò׵õ½Ó¦Öú
2Â¥2011-07-19 08:13:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s disease (41¨C44). Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate these receptors and probe their function (43, 44). Table 1 summarizes the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.
126´Ê=50½ð±Ò£¡
3Â¥2011-07-19 10:50:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

In addition to their potential as an antitussive target, Sig-Rs have been implicated in a wide range of physiological functions and thus represent a unique therapeutic target for disorders such as depression, schizophrenia, and Parkinson¡¯s disease (41¨C44). ³ýÁË×÷ΪDZÔÚµÄÕò¿È°Ð±ê£¬Sig-RÓëÐí¶àÉúÀí¹¦ÄÜÏà¹Ø£¬Òò¶øÓпÉÄÜ×÷ΪijЩ¼²²¡ÈçÒÖÓôÖ¢¡¢¾«Éñ·ÖÁÑÖ¢ºÍÅÁ½ðÉ­Êϲ¡µÈµÄÖÎÁưбꡣ
4Â¥2011-07-19 16:47:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

8814402

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡ï ¡ï
Mally89(½ð±Ò+2): ¸ÐлӦÖú£¡~ÐÁ¿àÁË£¡~ 2011-07-23 22:09:02
Although the precise role of Sig-Rs is not well understood, it is widely believed that the effects of Sig-Rs can be attributed to their modulation of other receptor types. ¾¡¹Ü¶ÔÓÚSig-RµÄÃ÷È·½ÇÉ«ÉÐδÍêÈ«²ûÃ÷£¬µ«±È½Ï¹«ÈϵÄÊÇSig-RµÄЧӦ¿ÉÒÔ¹é½áÓÚËüÃÇ¶ÔÆäËûÊÜÌåÀàÐ͵ĵ÷½Ú¡£This neuromodulatory role has complicated research on Sig-Rs and underscores the benefit of finding new compounds to modulate these receptors and probe their function (43, 44). Sig-RÕâÖÖÉñ¾­µ÷½Ú½ÇÉ«µÄ¸´ÔÓÑо¿Í¹ÏÔ·¢ÏÖµÄÄܹ»µ÷½ÚÕâЩÊÜÌ岢̽Ë÷ÕâЩÊÜÌ幦ÄܵÄл¯ºÏÎïµÄÒæ´¦¡£Table 1 summarizes the overall yields for the initial library efforts as well as exploratory screening for ¦Ê opioid receptor (KOR), sigma 1, and sigma 2 receptor binding (Ki values) for these compounds.±í1×ܽáÁËÕâЩ»¯ºÏÎïµÄ³õÆÚÎĿ⹤×÷ÒÔ¼°Õë¶Ô¦Ê°¢Æ¬ÊÜÌå¡¢sigma 1ºÍsigma 2ÊÜÌå½áºÏµÄÊÔÑéɸѡµÄÕûÌå×´¿ö¡£
5Â¥2011-07-19 17:05:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÑÌÔÆÌýÓê µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á +9 yunziaaaaa 2026-03-01 10/500 2026-03-02 15:18 by °ë½ØµÄÊ«0927
[¿¼ÑÐ] ²ÄÁÏ284Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧӢһÊý¶þר˶ +11 ÏëÉϰ¶µÄÍÁ²¦Êó 2026-02-28 11/550 2026-03-02 15:13 by ÏòÉϵÄÅÖ¶«
[¿¼²©] ³ÏÕÐũҵ²©Ê¿ +3 ÐÄÐÀÏòÈÙ 2026-02-28 3/150 2026-03-02 13:33 by ʱ¼ä²»¹·
[¿¼ÑÐ] 291 Çóµ÷¼Á +3 »¯¹¤2026½ì±ÏÒµÉ 2026-03-02 3/150 2026-03-02 12:55 by houyaoxu
[¿¼ÑÐ] 275Çóµ÷¼Á +4 Ã÷Ô¶Çóѧ 2026-03-01 4/200 2026-03-02 12:45 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 292Çóµ÷¼Á +7 yhk_819 2026-02-28 7/350 2026-03-02 12:43 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁϹ¤³Ì274Çóµ÷¼Á +4 Lilithan 2026-03-01 4/200 2026-03-02 12:06 by yuchj
[¿¼ÑÐ] 295Çóµ÷¼Á +8 19171856320 2026-02-28 8/400 2026-03-02 11:19 by yuchj
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +6 °®²Áº¹µÄ¿ÉÀÖ±ù 2026-02-28 7/350 2026-03-02 10:42 by Jy?
[¿¼ÑÐ] 0854¸´ÊÔµ÷¼Á 276 +4 wmm9 2026-03-01 6/300 2026-03-02 09:28 by ÈÈÇéɳĮ
[¿¼ÑÐ] ²ÄÁÏÀàÇóµ÷¼Á +11 wana_kiko 2026-02-28 14/700 2026-03-02 08:46 by ´ÏÃ÷µÄ´óËÉÊó
[»ù½ðÉêÇë] ±¾×ÓдÍêÁË£¬¸øDSÐֵܿ´ÁË£¬µÃÁË92·Ö +3 Doma 2026-03-01 7/350 2026-03-02 00:00 by jnzsy
[¿¼ÑÐ] 299Çóµ÷¼Á +3 YÄ«Ã÷ÆåÃîY 2026-02-28 5/250 2026-03-01 21:01 by tangxiaotian
[¿¼ÑÐ] »¯¹¤299·ÖÇóµ÷¼Á Ò»Ö¾Ô¸985Âä°ñ +5 ÎûÎû(*^¦Ø^*) 2026-03-01 5/250 2026-03-01 19:47 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 0856²ÄÁÏÇóµ÷¼Á +11 hyf hyf hyf 2026-02-28 12/600 2026-03-01 18:57 by 18137688336
[¿¼ÑÐ] 0856²ÄÁÏÇóµ÷¼Á +4 ÂéÀ±öÏÓã 2026-02-28 4/200 2026-03-01 16:51 by caszguilin
[»ù½ðÉêÇë] ¸Õ¼Óã¬Ã»ÓÐÆÚ¿¯ºÅ£¬µ«ÊÇÔÚÏ߿ɿ´µÄÂÛÎÄ¿ÉÒÔ·ÅΪ´ú±í×÷Âð 10+3 arang1 2026-03-01 3/150 2026-03-01 16:43 by babero
[¿¼ÑÐ] 313Çóµ÷¼Á +3 Ë®Á÷Äêlc 2026-02-28 3/150 2026-03-01 16:01 by ÐÂÄÜÔ´´ïÈË
[¿¼ÑÐ] 298Çóµ÷¼Á +9 È˼äΨÄãÊÇÇå»¶ 2026-02-28 12/600 2026-03-01 14:23 by Ducount.Y
[ÂÛÎÄͶ¸å] ÇóÖúcoordination chemistry reviews µÄд×÷Ä£°å 10+3 ljplijiapeng 2026-02-27 4/200 2026-03-01 09:07 by babero
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û